MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-022-11893-7

Медицинская библиотека · Annals of surgical oncology · 2022

Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.

Ricotta Giulio, Maulard Amandine, Candiani Massimo, Scherrier Stephanie, Genestie Catherine, Pautier Patricia, Leary Alexandra, Chargari Cyrus, Mangili Giorgia, Morice Philippe, Gouy Sébastien

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Endometrioid borderline ovarian tumor (EBOT) is a rare subtype of borderline ovarian malignancies. This study was designed to determine the prognosis of a series of EBOT.

METHODS

This is a retrospective review of patients with EBOT treated in or referred to our institutions and a centralized, histological review by a reference pathologist. Data on the clinical characteristics, management (surgical and medical), and oncologic outcomes of patients were required for inclusion.

RESULTS

Forty-eight patients were identified. Median age was 52 years (range 14-89). Fourteen patients underwent a conservative surgery and 32 a bilateral salpingo-oophorectomy (unknown in 2 cases). Two patients had bilateral tumors. Forty-three patients had stage I disease, and five patients had stage II disease (10%). Stromal microinvasion and intraepithelial carcinoma was observed in 6 (12%) and 13 (27%) patients respectively. Endometriosis was histologically associated in 12 patients (25%). Synchronous endometrial disease was found in 7 (24%) of 29 patients with endometrial histological evaluation. The median follow-up was 72 months (range 6-146). Two patients developed a recurrence after cystectomy in form of borderline disease (5%). No death related to EBOT occurred.

CONCLUSIONS

Peritoneal restaging surgery should be performed if not realized initially, because 5% of EBOTS are diagnosed at stage II-III. Fertility-sparing surgery seems a safe option in selected patients. Because synchronous endometrial diseases, including endometrial carcinoma are frequent, systematic hysterectomy (or endometrial sampling in case of fertility-sparing surgery) is mandatory. Prognosis is generally excellent. Recurrence is a rare event (6%), but it can occur in the form of invasive disease.

Для цитирования: Ricotta Giulio, Maulard Amandine, Candiani Massimo, Scherrier Stephanie, Genestie Catherine, Pautier Patricia, Leary Alexandra, Chargari Cyrus, Mangili Giorgia, Morice Philippe, Gouy Sébastien. Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.. Annals of surgical oncology. 2022. DOI: 10.1245/s10434-022-11893-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.